NES and acute myeloid leukemia: Although this study demonstrates a key role for NESTIN+ BMSC-dependent GSH and GPX in antioxidant protection of leukemic cells against chemotherapy, it does not exclude the possibility that other antioxidant pathways and cell types contribute to buffer excessive ROS in AML.